Metrion Biosciences closes £3.7m new equity financing

Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, today announced that it has secured £3.5m in new equity financing, including £2.5m from lead investor Maven Capital Partners (Maven) and £1 million from existing investor, Gresham House Ventures (Gresham House).

Related Keywords

United Kingdom ,Cambridge ,Cambridgeshire ,Barry Kenny ,Metrion Biosciences Limiteddec ,Marc Rogers ,David Milroy ,Mark Keogh ,Andy Southan ,Steve Carle ,Keith Mccullagh ,Metrion Biosciences ,Metrion Biosciences Limited ,From Metrion Biosciences Limiteddec ,Biosciences Limited ,Maven Capital Partners ,Gresham House Ventures ,Gresham House ,Amaya Ward ,